(Q36181275)

12 August 2017

The potential use of MMP inhibitors to treat CNS diseases (English)

1 reference

12 August 2017

Yong VW

1

1 reference

PubMed ID

15992076

12 August 2017

language of work or name

English

0 references

publication date

1 March 1999

1 reference

Expert Opinion on Investigational Drugs

12 August 2017

1 reference

12 August 2017

8

1 reference

12 August 2017

3

1 reference

12 August 2017

255-268

1 reference

Focalized proteolysis: spatial and temporal regulation of extracellular matrix degradation at the cell surface

12 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.3.255

Transmembrane-deletion mutants of the membrane-type matrix metalloproteinase-1 process progelatinase A and express intrinsic matrix-degrading activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.3.255

Matrix metalloproteinases and diseases of the CNS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.3.255

Regulation of extracellular matrix degradation by cell-extracellular matrix interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.3.255

Biology of tumor cell invasion: interplay of cell adhesion and matrix degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.3.255

Human 72-kilodalton type IV collagenase forms a complex with a tissue inhibitor of metalloproteases designated TIMP-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.3.255

Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.3.255

Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.3.255

Regulation of matrix metalloproteinase-9 and inhibition of tumor invasion by the membrane-anchored glycoprotein RECK

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.3.255

Extracellular matrix-degrading proteinases in the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.3.255

Changing views of the role of matrix metalloproteinases in metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.3.255

Tumor cell interactions with the extracellular matrix during invasion and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.3.255

Marked acceleration of the metastatic phenotype of a rat bladder carcinoma cell line by the expression of human gelatinase A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.3.255

Matrix metalloproteinase degradation of extracellular matrix: biological consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.3.255

Intestinal tumorigenesis is suppressed in mice lacking the metalloproteinase matrilysin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.3.255

Expression of 72 kDa type IV collagenase and invasion activity of human glioma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.3.255

Glioma invasion in vitro: regulation by matrix metalloprotease-2 and protein kinase C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.3.255

Expression of tissue inhibitors of metalloproteinases: negative regulators of human glioblastoma invasion in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.3.255

Expression and localization of 72 kDa type IV collagenase (MMP-2) in human malignant gliomas in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.3.255

Expression of matrix metalloproteinases and their tissue inhibitors in human brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.3.255

Proteolytic enzyme activity of blood leukocytes and cerebrospinal fluid in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.3.255

Degradation of basic protein in myelin by neutral proteases secreted by stimulated macrophages: A possible mechanism of inflammatory demyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.3.255

Degradation of myelin basic protein by cerebrospinal fluid: Preservation of antigenic determinants under physiological conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.3.255

Gelatinase in the cerebrospinal fluid of patients with multiple sclerosis and other inflammatory neurological disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.3.255

Matrix metalloproteinase-9 (gelatinase B) is selectively elevated in CSF during relapses and stable phases of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.3.255

Effect of steroids on CSF matrix metalloproteinases in multiple sclerosis: relation to blood-brain barrier injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.3.255

Enhanced expression of MMP-7 and MMP-9 in demyelinating multiple sclerosis lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.3.255

Matrix metalloproteinase-9 and -7 are regulated in experimental autoimmune encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.3.255

Metalloelastase is required for macrophage-mediated proteolysis and matrix invasion in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.3.255

TIMP-2 reduces proteolytic opening of blood-brain barrier by type IV collagenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.3.255

Matrix metalloproteinases, tumor necrosis factor and multiple sclerosis: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.3.255

Matrix metalloproteinase expression in an experimentally-induced DTH model of multiple sclerosis in the rat CNS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.3.255

Delayed-type hypersensitivity lesions in the central nervous system are prevented by inhibitors of matrix metalloproteinases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.3.255

Cytokine-regulated proteases in autoimmune diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.3.255

Macrophage metalloelastase degrades matrix and myelin proteins and processes a tumour necrosis factor-alpha fusion protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.3.255

Reversal of experimental autoimmune encephalomyelitis with a hydroxamate inhibitor of matrix metalloproteases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.3.255

Effective treatment of models of multiple sclerosis by matrix metalloproteinase inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.3.255

Interferon beta-1b decreases the migration of T lymphocytes in vitro: effects on matrix metalloproteinase-9.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.3.255

Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.3.255

A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.3.255

Gelatinase A possesses a beta-secretase-like activity in cleaving the amyloid protein precursor of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.3.255

Characterization of Neutral Proteinases from Alzheimer-Affected and Control Brain Specimens: Identification of Calcium-Dependent Metalloproteinases from the Hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.3.255

Degradation of amyloid beta-protein by a metalloprotease secreted by microglia and other neural and non-neural cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.3.255

Subtractive cloning identifies tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) increased gene expression following focal stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.3.255

Increased gelatinase A (MMP-2) and gelatinase B (MMP-9) activities in human brain after focal ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.3.255

Matrix metalloproteinases contribute to the blood-brain barrier disruption during bacterial meningitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.3.255

Matrix metalloproteinases and tissue inhibitors of metalloproteinases in viral meningitis: upregulation of MMP-9 and TIMP-1 in cerebrospinal fluid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.3.255

The metalloproteinase stromelysin-1 (transin) mediates PC12 cell growth cone invasiveness through basal laminae

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.3.255

Oligodendrocyte-type 2 astrocyte progenitors use a metalloendoprotease to spread and migrate on CNS myelin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.3.255

Oligodendrocytes utilize a matrix metalloproteinase, MMP-9, to extend processes along an astrocyte extracellular matrix.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.3.255

Kuzbanian controls proteolytic processing of Notch and mediates lateral inhibition during Drosophila and vertebrate neurogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.3.255

Evaluation of gelatinases and IL-6 in the cerebrospinal fluid of patients with optic neuritis, multiple sclerosis and other inflammatory neurological diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.3.255

The Expression of Tissue-type Plasminogen Activator, Matrix Metalloproteases and Endogenous Inhibitors in the Central Nervous System in Multiple Sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.3.255

Processing of tumour necrosis factor-α precursor by metalloproteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.3.255

21 January 2018

Identifiers

DOI

10.1517/13543784.8.3.255

1 reference

12 August 2017

1 reference

PubMed ID

15992076